Loading clinical trials...
Loading clinical trials...
A prospective study for long-term follow-up (LTFU) to evaluate safety and efficacy in subjects who participated in the Phase 1/2 randomized placebo-controlled trial MESRIX.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
NCT05530655 · Prostate Cancer, Radiation Toxicity, and more
NCT05417737 · Radiation Toxicity, Chemotherapeutic Toxicity, and more
NCT06033183 · Radiosensitivity, Pediatric Cancer, and more
NCT04940936 · Decision Making, Shared, Stereotactic Body Radiation Therapy, and more
NCT03972072 · Head and Neck Cancer, Xerostomia Due to Radiotherapy
Department of Otolaryngology, University Hospital of Copenhagen
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions